Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3

被引:136
|
作者
Gui, Chunshan [1 ]
Miao, Yi [1 ]
Thompson, Lucas [1 ]
Wahlgren, Bret [1 ]
Mock, Melissa [3 ]
Stieger, Bruno [3 ]
Hagenbuch, Bruno [1 ,2 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Kansas Mason Canc Res Inst, Kansas City, KS 66103 USA
[3] Univ Zurich Hosp, Dept Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
关键词
organic anion transporting polypeptide; hepatocyte; drug-drug interaction; nuclear receptor ligand;
D O I
10.1016/j.ejphar.2008.01.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor is a ligand-activated transcription factor that is abundantly expressed in hepatocytes. Numerous drugs are pregnane X receptor ligands. To bind to their receptor they must cross the sinusoidal membrane. Organic anion transporting polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) are polyspecific transporters expressed at the sinusoidal membrane of human hepatocytes. They mediate transport of a variety of drugs including the pregnane X receptor ligands rifampicin and dexamethasone. To test whether additional pregnane X receptor ligands interact with OATP1B1 - and 1B3-mediated transport, we developed Chinese Hamster Ovary (CHO) cell lines stably expressing OATP1B1 or 1B3 at high levels. OATP1B1- and 1B3-mediated estradiol-17 beta-glucuronide uptake was inhibited by several pregnane X receptor ligands in a concentration dependent way. IC50 values for rifampicin, paclitaxel, mifepristone, and troglitazone were within their respective pharmacological free plasma concentrations. Kinetic analysis revealed that clotrimazole inhibits OATP1B1-mediated estradiol-17 beta-glucuronide transport with a K-i of 7.7 +/- 0.3 mu M in a competitive way. However, uptake of OATP1B3-mediated estradiol-17 beta-glucuronide was stimulated and this stimulation was due to an increased apparent affinity. Transport of estrone-3-sulfate was hardly affected while all other substrates tested were inhibited. Additional azoles like fluconazole, ketoconazole and miconazole did not stimulate OATP1B3-mediated estradiol-17 beta-glucuronide transport. In summary, these results demonstrate that pregnane X receptor ligands, by inhibiting or stimulating OATP-mediated uptake, can lead to drug-drug interactions at the transporter level. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 50 条
  • [21] Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
    Hirano, M
    Maeda, K
    Shitara, Y
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01): : 139 - 146
  • [22] Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s
    Sun, Xiaolin
    Li, Junxiu
    Guo, Chaorui
    Xing, Han
    Xu, Jie
    Wen, Yanli
    Qiu, Zhixia
    Zhang, Qiuyang
    Zheng, Yi
    Chen, Xijing
    Zhao, Di
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (04) : 269 - 275
  • [23] Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
    Garrison, Dominique A.
    Talebi, Zahra
    Eisenmann, Eric D.
    Sparreboom, Alex
    Baker, Sharyn D.
    PHARMACEUTICS, 2020, 12 (09) : 1 - 18
  • [24] Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers
    Liu, Lichuan
    Cui, Yunhai
    Chung, Alfred Y.
    Shitara, Yoshihisa
    Sugiyama, Yuichi
    Keppler, Dietrich
    Pang, K. Sandy
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (01): : 395 - 402
  • [25] OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP
    Zhang, Yuchen
    Ruggiero, Melissa
    Hagenbuch, Bruno
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (08) : 622 - 630
  • [26] The effect of well-known inhibitors of efflux transporters on the uptake transporters, OATP1B1 and OATP1B3
    Matsushima, Soichiro
    Maeda, Kazuya
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2006, 38 : 60 - 61
  • [27] The Effect of Original Russian Neurotropic Drugs on Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3
    P. D. Erokhina
    Yu. V. Abalenikhina
    P. Yu. Mylnikov
    A. V. Petrov
    S. O. Ganina
    E. A. Konyakhin
    A. V. Shchulkin
    E. N. Yakusheva
    Bulletin of Experimental Biology and Medicine, 2023, 176 : 170 - 175
  • [28] Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
    Powell, John T.
    Kayesh, Ruhul
    Ballesteros-Perez, Alexandra
    Alam, Khondoker
    Niyonshuti, Pascaline
    Soderblom, Erik J.
    Ding, Kai
    Xu, Chao
    Yue, Wei
    PHARMACEUTICS, 2024, 16 (01)
  • [29] Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3
    Bednarczyk, Dallas
    ANALYTICAL BIOCHEMISTRY, 2010, 405 (01) : 50 - 58
  • [30] The Effect of Original Russian Neurotropic Drugs on Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3
    Erokhina, P. D.
    Abalenikhina, Yu. V.
    Mylnikov, P. Yu.
    Petrov, A. V.
    Ganina, S. O.
    Konyakhin, E. A.
    Shchulkin, A. V.
    Yakusheva, E. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 176 (02) : 170 - 175